IDS p.Ser87Asn
c.260G>A · VCV3255637
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9864 | likely pathogenic · top 3% in IDS |
|---|---|---|
| REVEL | 0.899 | moderately pathogenic-leaning |
| SaProt | LLR -11.89 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | Δ0.47 | acceptor gain · deltas |
| Pangolin | Δ0.30 | gain · loss 0.11 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 7.4 | GERP 1.1, phastCons 1 |
| Regional constraint | o/e 0.07 | constrained · MANE · 819 bp · p 6.4e-10 · regional, not allelic |
| Overall | ||
| CADD | 32.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- IDS
- Protein
- p.Ser87Asn
- Coding
- c.260G>A
- MANE Select
- NM_000202
- Type
- single nucleotide variant
- Location
- chrX:149503470 (GRCh38)
- Structure
- AlphaFold pLDDT 93.39 · 2 PDB
- Residue 87
- an α-helix; a UniProt-annotated variant site (in mps2; mild form)
Disease context
mucopolysaccharidosis type 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Mucopolysaccharidosis type 2 (Orphanet):
- Inheritance
- X-linked recessive
- Onset
- Childhood
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- IDS p.Ser87Arg Pathogenic ★ same residue
- IDS p.Ser87Thr Pathogenic ★ same residue
- IDS c.1006+1G>C Pathogenic ★★ same condition
- IDS c.1006+1G>T Pathogenic ★★ same condition
- IDS c.1007-133A>G Likely pathogenic ★★ same condition
- IDS c.1007-1G>A Pathogenic ★★ same condition
- IDS c.1007-2A>C Pathogenic/Likely pathogenic ★★ same condition
- IDS c.1007-8T>G Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ids-p-ser87asn (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown